Haemonetics 3rd Quarter Fiscal 2018 Earnings Release Available on Investor Relations Website
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- AI stocks lift Wall St as oil falls, Treasury yields decline
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
- Novo Nordisk shares drop as investor event disappoints
Haemonetics (HAE) PT Raised to $56 at Craig-Hallum; 'Valuation Remains a Concern'
February 7, 2018 9:07 AM ESTCraig-Hallum raised its price target on Haemonetics (NYSE: HAE) to $56.00 (from $50.00) while maintaining a Hold rating.
... MoreHaemonetics (HAE) Tops Q3 Views; Announces $260M Stock Buyback Plan
February 6, 2018 6:13 AM ESTHaemonetics (NYSE: HAE) reported Q3 EPS of $0.62, which may note compare to the analyst estimate of $0.44. Revenue for the quarter came in at $234 million versus the consensus estimate of $227.67 million.
Chris Simon, Haemonetics CEO, stated: Our strategy is working and we have good momentum... More
